A novel oral COVID-19 vaccine will be developed by Jerusalem-based Oramed Pharmaceuticals through a new company, Oravax Medical, using Oramed’s proprietary oral delivery technology and India-based Premas Biotech’s novel vaccine technology. In a pilot study [...]
